Elvitegravir is an antiretroviral drug used in the treatment of HIV infection. It belongs to a class of drugs known as integrase inhibitors, which block the action of the integrase enzyme. This enzyme is crucial for HIV replication, as it facilitates the integration of viral DNA into the host cell genome.
